Mefenamic Acid Strides Pharma Uk

Mefenamic acid, the active ingredient in Mefenamic Acid Strides Pharma, is a NSAID (fenamate) presented as a oral tablet for systemic use. It treats mild to moderate pain, menstrual pain and inflammatory conditions such as arthritis. The drug belongs to the fenamate subclass of non‑steroidal anti‑inflammatory agents and works by inhibiting cyclooxygenase enzymes, thereby reducing prostaglandin synthesis and associated discomfort. It is commonly prescribed for short‑term management of acute pain episodes and is available only by prescription in most jurisdictions.

GNH USA supplies Mefenamic Acid Strides Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mefenamic acid is an NSAID that reduces inflammation and pain by targeting the cyclooxygenase pathway.

- Mild to moderate pain: provides analgesic relief for acute pain such as dental or musculoskeletal discomfort. - Dysmenorrhea: alleviates menstrual cramps and associated pelvic pain. - Arthritis: reduces inflammation and pain in osteoarthritis or rheumatoid arthritis flares.

Mefenamic acid may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Gastrointestinal upset: nausea, dyspepsia, or abdominal discomfort. - Headache: mild to moderate intensity. - Dizziness: transient sensation of light‑headedness. - Rash: mild skin irritation or erythema.

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulceration. - Renal impairment: reduced kidney function or acute kidney injury. - Hepatic dysfunction: elevated liver enzymes or hepatitis. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Anaphylaxis: life‑threatening allergic response. - Blood dyscrasias: agranulocytosis or aplastic anemia.

Before prescribing mefenamic acid, clinicians should consider several safety measures.

- Assess renal function: adjust use in patients with impaired kidney function. - Monitor hepatic function: avoid in severe liver disease. - Avoid in third trimester pregnancy: risk to the fetus. - Use caution with concurrent NSAIDs or anticoagulants: increased bleeding risk. - Store at ambient temperature below 25°C: keep in the original pack, protect from moisture.

Mefenamic acid can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Other NSAIDs or COX‑2 inhibitors: additive gastrointestinal toxicity. - Selective serotonin reuptake inhibitors (SSRIs): heightened hemorrhage risk.

Moderate Interactions (Monitor Closely): - ACE inhibitors or diuretics: may reduce renal function. - Lithium: NSAIDs can increase lithium levels. - Methotrexate: reduced clearance leading to toxicity.